Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Diabetes & Metabolic Syndrome|May 21, 2023
Protein restriction in adults with chronic kidney disease, with or without diabetes: Integrated Diabetes and Endocrine Academy (IDEA) consensus statement for Indian patientsSubir Ray, Awadhesh Kumar Singh, Jagat Jyoti Mukherjee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 18, 2015
PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South AsiansRaja Ramachandran, Vinod Kumar, Ashwani Kumar, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trialRaja Ramachandran, Harsha Kumar Hn, Vinod Kumar, et al.
Rheumatology International|February 6, 2022
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based reviewArun Prabhahar, G S R S N K Naidu, Prabhat Chauhan, et al.
Kidney International Reports|November 17, 2017
Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and CyclophosphamideRaja Ramachandran, Ashok Kumar Yadav, Vinod Kumar, et al.
Kidney International Reports|October 11, 2022
Challenges in Diagnosis and Management of Glomerular Disease in Resource-Limited SettingsRaja Ramachandran, Shabna Sulaiman, Prabhat Chauhan, et al.
Seminars in Nephrology|April 14, 2023
Chronic Kidney Disease Burden in Low-Resource Settings: Regional PerspectivesIfeoma I Ulasi, Olugbenga Awobusuyi, Saurabh Nayak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 7, 2020
Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysisSunil Taneja, Ajay Duseja, Manu Mehta, et al.
Rheumatology International|August 2, 2022
Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyJoydeep Samanta, Gsrsnk Naidu, Prateek Deo, et al.
Kidney International Reports|February 3, 2026
Corrigendum to "Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy" [<i>Kidney International Reports</i> Volume 10, Issue 11, November 2025, Pages 3785-3795]Raja Ramachandran, Prabhat Chauhan, Joyita Bharati, et al.
Pageof 13